Medicare Enrolled

Dr. Roy Akarakian, MD

Sports Medicine (Emergency Medicine) Physician · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1500 SAN PABLO ST, Los Angeles, CA 90033
3234428500
In practice since 2018 (8 years)
NPI: 1295232338 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Akarakian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akarakian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Akarakian

Dr. Roy Akarakian is a sports medicine physician in Los Angeles, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Akarakian performed 1,768 Medicare services across 697 unique beneficiaries.

Between the years covered by Open Payments, Dr. Akarakian received a total of $11,214 from 9 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (emergency medicine) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Akarakian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 17% volume in CA $11,214 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,768
Medicare services
Top 17% in CA for sports medicine (emergency medicine) physician
697
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~221 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
870 $0 $75
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
201 $0 $75
Emergency department visit, high complexity
An emergency department visit involving a high level of medical decision making.
154 $137 $740
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
114 $7 $40
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $73 $142
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
91 $89 $176
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
63 $174 $890
Emergency department visit, moderate complexity
An emergency department visit for an established or new patient involving a moderate level of medical decision making.
57 $95 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $105 $201
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $120 $535
New patient office visit, complex (60-74 min) 27 $139 $750
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $127 $261
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
54.4% medium
34.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,214
Total received (2021-2024)
Avg $2,803/year across 4 years
Top 11% in CA for sports medicine (emergency medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,607 (85.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,607 (14.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$994
2023
$473
2022
$4,941
2021
$4,807

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pacira Pharmaceuticals Incorporated
$790
DePuy Synthes Sales Inc.
$149
Bioventus LLC
$37
Avanos Medical
$17
Top 3 companies account for 98.3% of 2024 payments
All-time payments by company (2021-2024) ›
Pinnacle, Inc
$9,607
Pacira Pharmaceuticals Incorporated
$790
Arthrex, Inc.
$373
DePuy Synthes Sales Inc.
$149
Janssen Pharmaceuticals, Inc
$108
NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
$100
Bioventus LLC
$37
Sonex Health, Inc.
$33
Avanos Medical
$17
Top 3 companies account for 96.0% of all-time payments
Associated products mentioned in payments ›
CEREPAK UNIFORM · Hera W10 · Iovera · SUPARTZ FX SODIUM HYALURONATE · TRIVISC SODIUM HYALURONATE · ULTRAGUIDECTR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in sports medicine (emergency medicine) physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a sports medicine physician in Los Angeles?
Compare sports medicine physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse sports medicine physicians nearby

Geographic Context

Sports medicine physicians within 10 mi
6
Per 100K population
0.1
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Akarakian is a mixed practice specialist, with above-average Medicare volume (top 17% in CA), with speaking/promotional industry engagement in the top 11% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Akarakian experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Akarakian performed 870 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akarakian receive payments from pharmaceutical companies?
Yes. Dr. Akarakian received a total of $11,214 from 9 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akarakian's costs compare to other sports medicine physicians in Los Angeles?
Dr. Akarakian's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akarakian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →